Executive Summary
On January 9, 2026, 54 8-K filings from predominantly small- and micro-cap firms (despite the Dow 30 stream focus) highlighted clusters of SPAC de-SPAC mergers, widespread leadership changes, multiple delistings, and auditor shifts, amid routine financial disclosures in biotechs. Bearish signals dominate via delistings (4 high-materiality cases) and accounting concerns, contrasting neutral M&A activity, indicating systemic distress in microcaps with dilution risks from unregistered equity sales. Institutional investors face elevated small-cap volatility; trim exposures to delisting-threatened names while eyeing post-merger SPAC alpha, as cumulative patterns suggest sector rotation away from compliant-challenged firms.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from January 07, 2026.
Investment Signals(4)
- β²
Multiple delistings signaling liquidity crises and compliance failures [BEARISH] - Onfolio Holdings, Advantage Solutions, TruGolf Holdings, Brag House Holdings
- β²
Auditor changes hinting at financial reporting weaknesses [BEARISH] - Hills Bancorporation, Vishay Intertechnology, Safe & Green Holdings
- β²
Non-reliance on prior financials indicating material accounting issues [BEARISH] - Southwest Gas Holdings
- β²
SPAC de-SPAC completions with control changes offering potential value unlock [BULLISH] - Welsbach Technology Metals Acquisition, Silicon Valley Acquisition
Risk Flags(3)
- βΌ
Cluster of 4 delistings (Item 3.01) across microcaps erodes liquidity and signals broad operational/financial distress
- βΌ
3 auditor changes (Item 4.01) plus Item 4.02 non-reliance raise systemic accounting control risks
- βΌ
Recurrent unregistered equity sales (Item 3.02 in 8+ filings) amplify portfolio dilution threats in small caps
Opportunities(3)
- β
SPAC mergers (Welsbach, Silicon Valley, La Rosa) with asset completions (Item 2.01) for post-deal catalysts and governance resets
- β
Biotech/pharma earnings wave (Immunocore, Perspective Therapeutics, NewAmsterdam) via Item 2.02 for sector momentum plays
- β
Leadership refreshes (15+ Item 5.02 filings) as entry points for stabilized governance in underfollowed names
Sector Themes(3)
- β
SPAC/M&A surge with 7+ filings on definitive agreements, asset completions, and control shifts signaling consolidation in acquisition vehicles
- β
Biotech/healthcare disclosure density (10+ firms with Reg FD, results) amid neutral sentiment, hinting at pipeline or trial updates
- β
Governance churn via 15+ officer/director changes (Item 5.02) cross-sector, potentially presaging strategic pivots or instability
Watch List(4)
- π
Delisting cluster (Onfolio, Advantage Solutions, TruGolf, Brag House) - Monitor for sharp declines and OTC transfers
- π
Auditor changers (Vishay, Safe & Green, Hills Bancorp) - Probe for disagreement disclosures or restatements
- π
Welsbach Technology Metals (8-K and 8-K/A) - Track merger target reveal and dilution impacts
- π
Southwest Gas Holdings - Assess Item 4.02 restatement scope for broader energy sector contagion
Filing Analyses(54)
09-01-2026
SUI Group Holdings Ltd. filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000201, Size: 202 KB), disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific financial statements/exhibits are provided. Sector not specified.
09-01-2026
SUI Group Holdings Ltd. filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000203, Size: 170 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected officer, position, appointment/resignation, reasons, or quantitative data provided in the filing summary. Sector not specified.
09-01-2026
Welsbach Technology Metals Acquisition Corp. filed an 8-K on 2026-01-09 (AccNo: 0001213900-26-002600, Size: 5 MB) disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of financial obligations (Item 2.03), unregistered equity sales (Item 3.02), modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), governance amendments (Item 5.03), and code of ethics amendments (Item 5.05). This indicates a significant merger/acquisition event likely involving a SPAC de-SPAC transaction, but target identity, deal terms, valuation, and financial details are NOT_DISCLOSED. Sector is not specified.
09-01-2026
Silicon Valley Acquisition Corp. filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-002599, Size: 331 KB), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements and exhibits (Item 9.01). This filing relates to a Merger/Acquisition event in the US market, but no specific parties, deal structure, valuation, or quantitative details are disclosed. Sector is not specified.
09-01-2026
RYVYL Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001185185-26-000081, Size: 26 MB), reporting unregistered sales of equity securities under Item 3.02 and financial statements and exhibits under Item 9.01. No details on transaction value, share count, or financial impacts are disclosed. This is a multi-item mandatory filing focused on equity securities compliance.
09-01-2026
uniQure N.V. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002317), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on core events, transactions, financial impacts, or numerical values are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure related to Regulation FD compliance.
09-01-2026
Immunocore Holdings plc filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000780, size 9 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other numerical data disclosed in the provided filing summary.
09-01-2026
Aquestive Therapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001398733-26-000003, Size: 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
09-01-2026
Perspective Therapeutics, Inc. filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-008277, Size: 274 KB) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
09-01-2026
RYVYL Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001185185-26-000092, Size: 205 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified; all quantitative financial metrics NOT_DISCLOSED.
09-01-2026
La Rosa Holdings Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002685, Size: 3 MB), reporting multiple material events including Entry into a Material Definitive Agreement (Item 1.01), Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), Unregistered Sales of Equity Securities (Item 3.02), Material Modifications to Rights of Security Holders (Item 3.03), and Amendments to Articles of Incorporation or Bylaws (Item 5.03), with Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided summary. Sector is not specified.
09-01-2026
Iovance Biotherapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001104659-26-002323, Size: 8 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector not specified.
09-01-2026
NewAmsterdam Pharma Co N.V. filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-008300, Size: 269 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure for a company in an unspecified sector. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.
09-01-2026
Intellia Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008307, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial impacts, or quantitative data are explicitly stated in the provided filing summary. This is a multi-item voluntary or mandatory disclosure depending on the underlying events, but core event details are NOT_DISCLOSED.
09-01-2026
Savara Inc filed a Form 8-K on January 09, 2026 (AccNo: 0001193125-26-008301, size: 6 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This is a general filing from the US SEC with sector not specified.
09-01-2026
Koppers Holdings Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001315257-26-000004, Size: 342 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or quantitative data provided in the summary; sector not specified.
09-01-2026
Aptevo Therapeutics Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008318, size: 700 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, equity sales, events, or quantitative data provided in the summary. Sector not specified.
09-01-2026
Ondas Holdings Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002694, Size: 200 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosure, events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
09-01-2026
Evolus, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001570562-26-000003, Size: 201 KB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This constitutes a multi-item voluntary disclosure of financial results. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.
09-01-2026
Onfolio Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001654954-26-000212, Size: 165 KB) disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. No specific reasons, financial details, transaction values, or quantitative impacts are provided in the available information. Sector is not specified.
09-01-2026
Vistra Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008508, Size: 147 KB) under Item 7.01 for Regulation FD Disclosure. No specific details on events, transactions, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.
09-01-2026
Origin Bancorp, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001516912-26-000004, Size: 222 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This appears to be a voluntary disclosure of material information, potentially including attached financial statements or exhibits. No core event details, transaction values, financial metrics, or other quantitative data are disclosed in the provided filing summary.
09-01-2026
HILLS BANCORPORATION filed a Form 8-K on January 9, 2026 (AccNo: 0000732417-26-000003), reporting under Item 4.01 a change in its certifying accountant. No details on the former or new auditor, reasons for change, financial impacts, or other quantitative data are disclosed in the provided filing summary. This is a single-item mandatory disclosure for a material event.
09-01-2026
Hong Yuan Holding Group filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001059, Size: 203 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or nature of change (appointment or departure) are stated.
09-01-2026
Kopin Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001064, size 199 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions, reasons, or terms are provided. Sector not specified.
09-01-2026
Venu Holding Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001075, Size: 2 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), and financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided summary. Sector not specified.
09-01-2026
ECB Bancorp, Inc. /MD/ filed a Form 8-K on January 09, 2026 (AccNo: 0001437749-26-000982, Size: 168 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. Sector not specified.
09-01-2026
Advantage Solutions Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008903, Size: 254 KB), reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on delisting reasons, financial impacts, transaction values, or sector are disclosed. This indicates a delisting event from the US market.
09-01-2026
MSP Recovery, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008897, size 1 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 2.04 triggering events accelerating or increasing such obligations, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. Sector not specified.
09-01-2026
LiveWire Group, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001898795-26-000008, Size: 174 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or any quantitative data are NOT_DISCLOSED in the provided information. Sector is not specified.
09-01-2026
BANK OF THE JAMES FINANCIAL GROUP INC filed a Form 8-K on January 09, 2026 (AccNo: 0001275101-26-000002, Size: 193 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, reason, or quantitative data provided in the filing summary.
09-01-2026
Charles River Laboratories International, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001603, Size: 142 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, nature of change (appointment or resignation), reasons, or compensation are provided. Sector not specified.
09-01-2026
Thryv Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000830, Size: 322 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided.
09-01-2026
CF Industries Holdings, Inc. filed a Form 8-K on January 09, 2026, under Item 8.01 Other Events. Accession Number: 0001104659-26-002476. File size: 187 KB; no specific event details, transaction values, or financial metrics disclosed.
09-01-2026
Vishay Intertechnology Inc filed a Form 8-K on January 9, 2026 (AccNo: 0000103730-26-000003, size 168 KB), reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No additional details on the change, reasons, new accountant, or exhibits are provided.
09-01-2026
Inflection Point Acquisition Corp. V filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-002931, Size: 280 KB) disclosing entry into a Material Definitive Agreement (Item 1.01), creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), and Financial Statements and Exhibits (Item 9.01). This pertains to a Merger/Acquisition event in an unspecified sector. No specific details on parties, structure, valuation, or terms are disclosed in the provided filing summary.
09-01-2026
Microvast Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0000947871-26-000019, Size: 276 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the officer involved, position affected, nature of change (appointment/resignation), reasons, or any quantitative data are provided in the filing summary.
09-01-2026
PEDEVCO CORP filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000231, Size: 151 KB), reporting under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.07 the submission of matters to a vote of security holders. No specific details on the nature, size, or terms of the financial obligation or the shareholder vote matters are disclosed in the provided filing summary. Sector is not specified.
09-01-2026
Boot Barn Holdings, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001104659-26-002514, Size: 4 MB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing reports financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.
09-01-2026
TruGolf Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001110, Size: 200 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the core event, reasons for delisting, financial impacts, transaction values, or other quantitative data are disclosed. Sector is not specified.
09-01-2026
Steven Madden, Ltd. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001108), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer, position, reason, or terms are provided in the filing summary.
09-01-2026
Abacus Global Management, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001644, Size: 1 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other quantitative data are disclosed. This appears to be a multi-item voluntary disclosure under Regulation FD.
09-01-2026
BED BATH & BEYOND, INC. filed a Form 8-K on January 09, 2026 (AccNo: 0001140361-26-000846, Size: 195 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
09-01-2026
NOVAGOLD RESOURCES INC filed a Form 8-K on January 9, 2026 (AccNo: 0001171843-26-000168, size 248 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This is a multi-item voluntary disclosure focused on Reg FD material information and attached exhibits.
09-01-2026
Vicarious Surgical Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002973, Size: 190 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This is a single-item filing disclosing shareholder vote results. No specific vote outcomes, proposals, numbers, or other details are provided.
09-01-2026
Southwest Gas Holdings, Inc. filed an 8-K on January 09, 2026 (AccNo: 0001692115-26-000004), disclosing Items 2.02 (Results of Operations and Financial Condition), 4.02 (Non-Reliance on Previously Issued Financial Statements or Related Audit Report), and 7.01 (Regulation FD Disclosure). No specific financial metrics, transaction values, or quantitative data are provided in the filing summary. This multi-item filing signals potential accounting issues alongside operational results.
09-01-2026
SAFE & GREEN HOLDINGS CORP. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002999, Size: 234 KB), reporting a change in its certifying accountant under Item 4.01 and attaching financial statements and exhibits under Item 9.01. No details on the former or new accountant, reasons for the change, financial impacts, or other specifics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure event.
09-01-2026
Sun Country Airlines Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009087, Size: 137 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
09-01-2026
Bark, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001646, Size: 215 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
09-01-2026
FLYEXCLUSIVE INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009100, Size: 986 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. Sector is not specified.
09-01-2026
Vistagen Therapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001690, size: 7 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the specific content of the disclosure or exhibits are provided. Sector not specified.
09-01-2026
Welsbach Technology Metals Acquisition Corp. filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-003038), disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), creation of financial obligations (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), amendments to articles/bylaws (Item 5.03), and code of ethics amendments (Item 5.05). No specific details on deal structure, parties, valuation, or financial metrics are disclosed in the provided filing summary.
09-01-2026
Enveric Biosciences, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001151, Size: 9 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no core event, transaction details, or quantitative financial data explicitly stated in the provided filing summary. Sector is not specified.
09-01-2026
Brag House Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-003029, Size: 189 KB), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No specific reasons for delisting, exchange involved, financial impacts, or transaction details are disclosed. Sector is not specified.
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 54 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC